Sorafenib is a drug widely used in treatment of HCC.[29] In mouse HCC tumor models, administration of sorafenib with ASO against Snora74a exhibited remarkable synergistic antitumor effect (Figure S9H–J, Supporting Information). This evidence concerns the gene SNORA74A and hepatocellular carcinoma.